Anesthesiology · Port St Lucie, FL
NPI
1013974450
Since 2006
Specialty
Anesthesiology
Code 207L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
10244 S US Highway 1
Port St Lucie, FL, 34952
Phone (772) 924-2527
Groups this clinician bills Medicare through
Medicare paid, 2024
$439K
11,192 services
Medicare patients, 2024
936
Average age 73
Drug cost, 2024
$669K
8,441 prescriptions
Company payments, 2025
$338
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jay Kuchera was code J1010 (injection, methylprednisolone acetate, 1 mg), 6,221 times for 66 patients. In total Jay Kuchera billed 11,192 services in 42 codes, and Medicare paid $439K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 6,221 | 66 | $0.10 | $653 |
| 99214 Office E&M - Established | Office | 1,757 | 728 | $101.28 | $178K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 715 | 52 | $0.09 | $63.6 |
| 80307 Drug Tests | Office | 649 | 381 | $60.48 | $39K |
| 99213 Office E&M - Established | Office | 620 | 410 | $72.25 | $45K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 573 | 353 | $152.79 | $88K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 72 | 61 | $194.77 | $14K |
| 98981 Care Management/Coordination | Office | 57 | 20 | $34.00 | $1,938 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 49 | 16 | $40.84 | $2,001 |
| 99203 Office E&M - New | Office | 46 | 46 | $83.61 | $3,846 |
| 98980 Care Management/Coordination | Office | 44 | 20 | $42.61 | $1,875 |
| 62323 Nerve Block Injection - Back | Office | 44 | 38 | $210.57 | $9,265 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 42 | 19 | $53.45 | $2,245 |
| 99204 Office E&M - New | Office | 42 | 42 | $141.89 | $5,960 |
| 64493 Nerve Block Injection - Back | Office | 32 | 22 | $214.40 | $6,861 |
By year: 2022 $502K for 6,688 services; 2023 $519K for 6,071 services; 2024 $439K for 11,192 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 649 | 381 | $60.48 | $39K |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 573 | 353 | $152.79 | $88K |
| G0482 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 72 | 61 | $194.77 | $14K |
Medicare prescription drug claims, 2024
In 2024, the drug Jay Kuchera prescribed most often to Medicare patients was Oxycodone-Acetaminophen (Oxycodone Hcl/Acetaminophen), with 2,554 prescriptions and refills. In total Jay Kuchera wrote 8,441 Medicare prescriptions that cost $669K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 2,554 | 2,555 | 551 | $109K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,339 | 1,339 | 332 | $34K |
| Morphine Sulfate Er Morphine Sulfate | 748 | 748 | 170 | $22K |
| Pregabalin Generic | 706 | 813 | 232 | $11K |
| Tramadol Hcl Generic | 328 | 339 | 99 | $2,175 |
| Morphine Sulfate Generic | 294 | 294 | 71 | $8,893 |
| Xtampza Er Oxycodone Myristate | 278 | 279 | 65 | $158K |
| Gabapentin Generic | 266 | 418 | 132 | $4,206 |
| Fentanyl Generic | 168 | 168 | 42 | $17K |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 153 | 156 | 31 | $15K |
| Tizanidine Hcl Generic | 142 | 218 | 74 | $1,549 |
| Buprenorphine Generic | 107 | 107 | 32 | $27K |
| Cyclobenzaprine Hcl Generic | 96 | 144 | 49 | $1,051 |
| Buprenorphine Hcl Generic | 93 | 93 | 23 | $2,295 |
| Tramadol Hcl Er Tramadol Hcl | 91 | 95 | 19 | $4,800 |
Brand drugs: 906 claims; generic drugs: 7,535 claims; opioid claims: 6,312.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jay Kuchera $338 ($338 in general payments such as food, travel and fees) from 7 companies. The largest payer was Si-Bone, Inc. with $154.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.